Bio-Path Holdings, Inc. (OTC:BPTH) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark P Colonnese Other companies: Vaxart, Inc. (Chief Financial Officer · Nov 2, 2015 – Apr 3, 2017 · Past); Precipio, Inc. (Chief Financial Officer · Sep 12, 2012 – Feb 18, 2014 · Past); Atherogenics Inc (VP Commercial Operations & CFO · Feb 21, 2006 – Dec 31, 2008 · Past) | Director · Jul 13, 2017 – Mar 28, 2019 · Past |
| Gillian C Ivers-Read Other companies: Clovis Oncology Inc (See Remarks · Nov 15, 2011 – Nov 1, 2022 · Past); Pharmion Corp (EVP, Development Operations · Dec 31, 2005 – Mar 7, 2008 · Past) | Director · Sep 10, 2008 – Apr 25, 2014 · Past |
| Aline Sherwood | Director · Mar 31, 2022 – Jul 30, 2024 · Past |
| Amy Sing | Director · Nov 3, 2014 – Mar 23, 2017 · Past |
| Douglas P Morris | Director · Sep 10, 2008 – Jul 30, 2024 · Past |
| Heath Cleaver | Director · Feb 11, 2014 – Jul 30, 2024 · Past |
| Michael J Garrison | Director · Oct 1, 2012 – Mar 23, 2017 · Past |
| Paul Aubert | Director · Feb 1, 2018 – Jul 30, 2024 · Past |
| Peter Henry Nielsen | President, CEO & CFO, Director · Mar 28, 2019 – Jul 30, 2024 · Past |
| Tamaro Martina Molsbergen | Director · Oct 11, 2019 – Mar 31, 2021 · Past |
| Thomas E Garrison | Director · Sep 10, 2008 – Dec 2, 2009 · Past |
| Ulrich W Mueller | COO & Secretary · Mar 26, 2014 – May 1, 2017 · Past |
| Vikram Grover | CEO | Board Chairman · Since at least Nov 5, 2026 |
| Wendy Charles | Chief Scientific Officer and Chief Ethics & Compliance Officer · Since at least Nov 4, 2026 |